ASX - By Stock
|
MEM |
Re:
Ann: $4.2m raise to pursue commercial opportunities with Felix
|
|
cunjevoi
|
5 |
1.4K |
1 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
5
|
1.4K
|
1
|
|
ASX - By Stock
|
MEM |
Re:
Ann: Trading Halt
|
|
cunjevoi
|
4 |
952 |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
4
|
952
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
cunjevoi
|
22K |
10M |
6 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
22K
|
10M
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
cunjevoi
|
22K |
10M |
3 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
22K
|
10M
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
cunjevoi
|
22K |
10M |
4 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
22K
|
10M
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Phase 1 onCARlytics CD19 virus clinical trial opens
|
|
cunjevoi
|
174 |
78K |
4 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
174
|
78K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene B Cell & OV Platforms Featured at ESMO Congress
|
|
cunjevoi
|
188 |
76K |
4 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
188
|
76K
|
4
|
|
Charts
|
IMU |
Re:
Class action
|
|
cunjevoi
|
288 |
120K |
5 |
20/09/23 |
20/09/23 |
Charts
|
288
|
120K
|
5
|
|
Charts
|
IMU |
Re:
Class action
|
|
cunjevoi
|
288 |
120K |
1 |
20/09/23 |
20/09/23 |
Charts
|
288
|
120K
|
1
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
cunjevoi
|
42K |
20M |
4 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
42K
|
20M
|
4
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
cunjevoi
|
42K |
20M |
2 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
42K
|
20M
|
2
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
cunjevoi
|
42K |
20M |
1 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
42K
|
20M
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Share Purchase Plan Closing Date Extended
|
|
cunjevoi
|
700 |
236K |
0 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
700
|
236K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Share Purchase Plan Closing Date Extended
|
|
cunjevoi
|
700 |
236K |
2 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
700
|
236K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Share Purchase Plan Closing Date Extended
|
|
cunjevoi
|
700 |
236K |
4 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
700
|
236K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Can they run a business?
|
|
cunjevoi
|
156 |
51K |
2 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
156
|
51K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Can they run a business?
|
|
cunjevoi
|
156 |
51K |
1 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
156
|
51K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Can they run a business?
|
|
cunjevoi
|
156 |
51K |
2 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
156
|
51K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Receives Positive Feedback From FDA
|
|
cunjevoi
|
115 |
46K |
7 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
115
|
46K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Can they run a business?
|
|
cunjevoi
|
156 |
51K |
6 |
10/09/23 |
10/09/23 |
ASX - By Stock
|
156
|
51K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Can they run a business?
|
|
cunjevoi
|
156 |
51K |
15 |
10/09/23 |
10/09/23 |
ASX - By Stock
|
156
|
51K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Can they run a business?
|
|
cunjevoi
|
156 |
51K |
14 |
10/09/23 |
10/09/23 |
ASX - By Stock
|
156
|
51K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
cunjevoi
|
22K |
10M |
1 |
10/09/23 |
10/09/23 |
ASX - By Stock
|
22K
|
10M
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
cunjevoi
|
22K |
10M |
2 |
09/09/23 |
09/09/23 |
ASX - By Stock
|
22K
|
10M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Can they run a business?
|
|
cunjevoi
|
156 |
51K |
2 |
09/09/23 |
09/09/23 |
ASX - By Stock
|
156
|
51K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Rubbing my ball
|
|
cunjevoi
|
1.6K |
900K |
2 |
09/09/23 |
09/09/23 |
ASX - By Stock
|
1.6K
|
900K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Can they run a business?
|
|
cunjevoi
|
156 |
51K |
4 |
09/09/23 |
09/09/23 |
ASX - By Stock
|
156
|
51K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Can they run a business?
|
|
cunjevoi
|
156 |
51K |
5 |
09/09/23 |
09/09/23 |
ASX - By Stock
|
156
|
51K
|
5
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
cunjevoi
|
42K |
20M |
8 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
42K
|
20M
|
8
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
cunjevoi
|
42K |
20M |
0 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
42K
|
20M
|
0
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
cunjevoi
|
42K |
20M |
5 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
42K
|
20M
|
5
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
cunjevoi
|
42K |
20M |
0 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
42K
|
20M
|
0
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
cunjevoi
|
42K |
20M |
1 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
42K
|
20M
|
1
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
cunjevoi
|
42K |
20M |
2 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
42K
|
20M
|
2
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
cunjevoi
|
1.0K |
627K |
0 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.0K
|
627K
|
0
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
cunjevoi
|
1.0K |
627K |
0 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.0K
|
627K
|
0
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
cunjevoi
|
1.0K |
627K |
0 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.0K
|
627K
|
0
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
cunjevoi
|
1.0K |
627K |
2 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.0K
|
627K
|
2
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
cunjevoi
|
1.0K |
627K |
0 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.0K
|
627K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: VAXINIA MAST Trial Clears Intratumoral Combination Cohort 1
|
|
cunjevoi
|
58 |
26K |
5 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
58
|
26K
|
5
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
cunjevoi
|
1.0K |
627K |
0 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.0K
|
627K
|
0
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
cunjevoi
|
1.0K |
627K |
0 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.0K
|
627K
|
0
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
cunjevoi
|
1.0K |
627K |
1 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.0K
|
627K
|
1
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
cunjevoi
|
1.0K |
627K |
0 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.0K
|
627K
|
0
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
cunjevoi
|
1.0K |
627K |
3 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
1.0K
|
627K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
SPP uptake
|
|
cunjevoi
|
153 |
55K |
0 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
153
|
55K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
SPP uptake
|
|
cunjevoi
|
153 |
55K |
4 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
153
|
55K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Appoints Dr John Byon as SVP Clinical Development
|
|
cunjevoi
|
63 |
24K |
0 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
63
|
24K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Appoints Dr John Byon as SVP Clinical Development
|
|
cunjevoi
|
63 |
24K |
13 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
63
|
24K
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Placement and Share Purchase Plan Update
|
|
cunjevoi
|
170 |
68K |
0 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
170
|
68K
|
0
|
|